How many drugs treat Hairy cell leukemia?

Drug Landscape tracks 5 marketed treatments for Hairy cell leukemia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hairy-cell-leukemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hairy cell leukemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hairy cell leukemia (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hairy cell leukemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Lumoxiti	MOXETUMOMAB PASUDOTOX	AstraZeneca		B-cell receptor CD22	2018-01-01
Nipent	PENTOSTATIN	Hospira Inc	Nucleoside Metabolic Inhibitor [EPC]	Adenosine deaminase	1991-01-01
Intron A	INTERFERON ALFA-2B	Merck & Co.	Interferon alpha		1986-01-01
Sitravatinib	sitravatinib	Pfizer	Tyrosine kinase inhibitor	Tyrosine kinases
Deoxycoformycin	Deoxycoformycin	Boston Medical Center		Adenosine deaminase, Adenosine deaminase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Hairy cell leukemia
AstraZeneca · 1 drug in Hairy cell leukemia
Boston Medical Center · 1 drug in Hairy cell leukemia
Hospira Inc · 1 drug in Hairy cell leukemia
Merck & Co. · 1 drug in Hairy cell leukemia
Pfizer · 1 drug in Hairy cell leukemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hairy cell leukemia:

Cite this brief

Drug Landscape (2026). Hairy cell leukemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hairy-cell-leukemia. Accessed 2026-06-10.

Hairy cell leukemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing